melagatran has been researched along with Endotoxemia in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Grimberg, E; Guron, G; Marcussen, N; Nitescu, N; Nordlinder, H; Ricksten, SE | 1 |
| Eriksson, M; Larsson, A; Mattsson, C; Saldeen, T | 2 |
3 other study(ies) available for melagatran and Endotoxemia
| Article | Year |
|---|---|
Effects of thrombin inhibition with melagatran on renal hemodynamics and function and liver integrity during early endotoxemia.
Topics: Animals; Anticoagulants; Azetidines; Benzylamines; Endotoxemia; Kidney; Lipopolysaccharides; Liver; Male; Rats; Rats, Sprague-Dawley; Renal Circulation; Thrombin | 2007 |
Melagatran, a low molecular weight thrombin inhibitor, counteracts endotoxin-induced haemodynamic and renal dysfunctions in the pig.
Topics: Animals; Azetidines; Benzylamines; Blood Coagulation; Creatinine; Diuresis; Drug Evaluation, Preclinical; Endotoxemia; Female; Fibrinolytic Agents; Glycine; Half-Life; Hemodynamics; Kidney; Male; Oxygen Consumption; Partial Thromboplastin Time; Platelet Count; Shock, Septic; Swine; Thrombin | 1998 |
Effects of melagatran, an inhibitor of thrombin, on fibrin deposits, haemodynamics, and platelet count in endotoxaemic pigs.
Topics: Animals; Anticoagulants; Azetidines; Benzylamines; Endotoxemia; Female; Fibrin; Glycine; Hemodynamics; Liver; Male; Platelet Count; Swine; Tumor Necrosis Factor-alpha | 2000 |